Add BrightSurf on Google Email

Johns Hopkins Medicine


New study finds link between difficulty identifying emotions and higher chronic pain levels

A large study found that individuals with difficulty recognizing and expressing emotions experience greater disruption to daily life from pain over time due to increased psychological distress. The study also suggests that addressing emotional processing difficulties may be key to improving long-term outcomes for people with chronic pain.

SourceJohns Hopkins Medicine·JournalHealth Psychology·DateApr 28, 2026

Mini brain-like structures grown in lab may help scientists treat, diagnose and stage Alzheimer’s disease

Researchers from Johns Hopkins Medicine have developed mini brain-like structures grown in the lab that could be used to evaluate how patients with Alzheimer's disease respond to certain drugs. The study found that tiny particles secreted by these brain tissues may contain cellular information that could help scientists find new biomar...

SourceJohns Hopkins Medicine·JournalAlzheimer’s & Dementia·DateApr 20, 2026

Johns Hopkins team develops therapeutic, nasally delivered DNA vaccine for tuberculosis

The Johns Hopkins team developed a therapeutic intranasal DNA vaccine against tuberculosis that accelerated disease clearance, improved treatment outcomes, and stimulated immune responses. The vaccine combines two genes to direct the immune system to fight drug-tolerant bacterial persisters, showing promise for treating TB.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateApr 1, 2026

New NIH-funded Johns Hopkins Medicine study finds switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV

Researchers found a 38% higher risk of diabetes in adults with HIV who switched from protease inhibitors to integrase inhibitors. The study suggests that medication changes may have adverse metabolic impacts, warranting close monitoring, regardless of weight gain.

SourceJohns Hopkins Medicine·JournalThe Lancet HIV·DateMar 30, 2026

The new cholesterol guideline: What to know

The new guideline focuses on lowering elevated LDL cholesterol levels and emphasizes the importance of earlier screenings, especially for those with a family history of heart disease. It also encourages more personalized risk estimations to support shared decision-making between clinicians and patients.

SourceJohns Hopkins Medicine·JournalJournal of the American College of Cardiology·TypeSystematic review·DateMar 27, 2026

Screening and preventive treatment program reduced tuberculosis incidence 83% among Tibetan children living in northern India

A recent study shows that a comprehensive TB screening and treatment program reduced TB incidence by 83% and prevalence of latent TB infection by 32% among Tibetan children in northern India. The program's success highlights the importance of community-led surveillance and treatment implementation to control TB transmission.

SourceJohns Hopkins Medicine·JournalThe Lancet Regional Health - Southeast Asia·DateMar 24, 2026

Adults with concurrent hearing and vision loss report barriers and challenges in navigating complex, everyday environments

A recent study found that adults with total or near-total vision loss who also experience hearing loss report lower confidence in their sound localization abilities, despite receiving specialized training. The researchers suggest that clinicians should account for hearing status during vision rehabilitation training to address individu...

SourceJohns Hopkins Medicine·JournalPLOS One·DateMar 11, 2026

New study offers strong evidence of elevated heart failure risk in adults with prediabetes, hypertension and subclinical heart injury or stress

A new study finds that adults with prediabetes and hypertension who have subclinical heart injury or stress are at increased risk of heart failure. The study highlights an at-risk population that can be identified using common cardiac biomarkers and emphasizes the importance of preventive care.

SourceJohns Hopkins Medicine·JournalJAMA Cardiology·DateMar 9, 2026

How bacteria may promote breast cancer

Pathogenic bacteria in gut and breast tissue can promote breast cancer development by increasing SMOX activity, leading to DNA damage and tumor growth. Targeting SMOX with inhibitors could be a viable strategy to counteract the cancer-promoting effects of microbial dysbiosis.

SourceJohns Hopkins Medicine·JournalCancer Research·DateFeb 16, 2026

Detecting early-stage cancers with a new blood test measuring epigenetic instability

Researchers at Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring DNA methylation patterns. The Epigenetic Instability Index (EII) successfully distinguished patients with early-stage lung and breast cancers from healthy individuals, showing promise in detecting...

SourceJohns Hopkins Medicine·JournalClinical Cancer Research·DateFeb 2, 2026

A new Johns Hopkins Medicine study suggests that certain sex hormones could play an important role in understanding long-term heart health — especially for men living with type 2 diabetes

Researchers found that higher testosterone levels reduced risk, while increased estradiol levels increased cardiovascular risk in male participants. In contrast, women with diabetes showed no significant link between hormone levels and cardiovascular outcomes.

SourceJohns Hopkins Medicine·JournalDiabetes Care·DateJan 26, 2026

Johns Hopkins Children’s Center study tracks declines in annual checkups as teens become young adults

A new study by Johns Hopkins Children's Center researchers found that as teens transition to young adults, they often skip yearly wellness visits with pediatricians or primary care providers. The study suggests that parents, pediatricians, and other primary care providers should encourage annual wellness visits to advance efforts in pr...

SourceJohns Hopkins Medicine·JournalJournal of Adolescent Health·DateJan 9, 2026

Experiments advance potential of protein that makes hydrogen sulfide as a therapeutic target for Alzheimer’s disease

Researchers have identified a key protein that produces hydrogen sulfide gas as a therapeutic target for Alzheimer's disease. Experiments in genetically engineered mice show that this protein, Cystathionine γ-lyase (CSE), plays a critical role in cognitive function and memory formation.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateDec 30, 2025

Cell-free DNA Could Detect Adverse Events from Immunotherapy

Researchers developed a non-invasive blood test to detect genetic material shed by tumors, which can identify adverse events related to immune checkpoint inhibitor therapy. The test found evidence of multi-organ injury in patients with immune-related adverse events, suggesting that the clinical syndromes may represent only a small frac...

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateDec 10, 2025

Protein plays unexpected dual role in protecting brain from oxidative stress damage

A new study from Johns Hopkins Medicine reveals that biliverdin reductase A plays a direct protective role against oxidative stress in neurons, independent of its role producing bilirubin. The enzyme modulates another key protein, NRF2, which regulates the levels of protective proteins and antioxidants in cells.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateNov 3, 2025